Lonial S, Richardson PG, Ferron-Brady G, Carreño F, Papathanasiou T, Ho YL, McKeown A, Brock K, Roy-Ghanta S, Melhem M, Mukhopadhyay P, Abdullah HA, Mateos M-V, Dimopoulos MA. Exposure-response and dose simulation of belantamab mafodotin in combination with standards of care in patients with relapsed/refractory multiple myeloma. haematol [Internet]. 2020Sep.10 [cited 2026Sep.15];. Available from: https://haematologica.org/article/view/14391